StockDrifts LogoStockDrifts

Latest SEC filings

Every 8-K, 10-Q, 10-K, Form 4 and 13D/G as it is filed, each one read and summarised so you can see what actually happened without opening the document.

Filing type

10-K
10-Q
8-K
6-K
Form 4
13D
13G
S-1

Event

Earnings
Guidance
M&A
Executive change
Insider trade
Equity offering
Buybacks & dividends
Index inclusion
Regulatory & legal

Insider action

Insider buy
Insider sell
DFTX
4
Sell

Definium Therapeutics, Inc.

CEO Robert Barrow sells $721.7K of stock under 10b5-1 plan

CEO Robert Barrow sold 19,023 shares for a total value of $721,732.62, executed under a 10b5-1 trading plan.

  • CEO Robert Barrow sold 19,023 shares.
  • The total value of the transaction was $721,732.62.
Bearish
Read the filing →

Companies on this page